UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal ...

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

On Monday, shares of Amedisys (NASDAQ:AMED), a healthcare company with a market capitalization of $2.95 billion, remained steady following the announcement of an extension to its merger agreement ...

Amedisys, Inc. (NASDAQ:AMED – Get Free Report) was the recipient of a significant drop in short interest in December. As of ...

The acquisition was originally expected to close this month, but in November the DOJ sued to block the merger.

On Monday, shares of Amedisys (NASDAQ:AMED), a healthcare company with a market capitalization of $2.95 billion, remained steady following the announcement of an extension to its merger agreement with ...

This article is available to HHCN+ members When Amedisys Inc. (Nasdaq: AMED) acquired Contessa Health for $250 million in 2021, it changed the home-based ...

On Monday, RBC Capital Markets sustained their positive outlook on Amedisys (NASDAQ:AMED) shares, maintaining an Outperform rating and a $100.00 price target. The affirmation follows recent ...

Since launching five years ago, a partnership among Contessa, Highmark Health and Allegheny Health Network (AHN) has expanded and started to prove out the ...

Medalogix, the leading data science and clinical decision support company specializing in the advancement of home-based ...

Amedisys Inc.’s (AMED) shares climbed 4.7% following news that the company extended the deadline to close its $3.3 billion merger plan with UnitedHealth Group Inc. (UNH). Shares of Lamb Weston ...